PROMOTE.eu

PROMOTE (PRostate cancer OMics Oriented inTErvention) is an innovative doctoral training network funded under the EU Horizon Europe Programme through the Marie Skłodowska-Curie Actions (MSCA). The project addresses critical challenges in prostate cancer diagnosis and treatment, integrating cutting-edge omics technologies and artificial intelligence (AI) methodologies. On this page, you'll be able to follow the groundbreaking research and activities of 8 dedicated doctoral researchers. With strong backgrounds across fields such as bioinformatics, systems biology, clinical research, and data science, our researchers are set to deliver novel insights and transformative solutions for prostate cancer management. PROMOTE brings together 13 academic, clinical, and industrial partners across Europe—including Germany, Austria, Greece, Portugal, and Spain. The collaborative synergy among these leading institutions and SMEs is designed to foster innovation and significantly impact personalized healthcare strategies. Stay tuned for regular updates on: ✅ Innovative research outcomes in prostate cancer proteomics, AI-driven diagnostics, and precision medicine. ✅ Highlights from international conferences, scientific events, and collaborative activities. ✅ Latest scientific publications, technological advancements, and impactful breakthroughs. Learn more about our project and partners here: https://www.eu-promote.com #PROMOTE_EU #MarieCurie #HorizonEurope #PhDlife #ProstateCancerResearch #Omics #ArtificialIntelligence #Biotechnology #LifeSciences #CancerResearch #Innovation